Schulhoff & Co’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
2,299
+4
+0.2% +$1.85K 0.49% 48
2026
Q1
$1.1M Buy
2,295
+93
+4% +$47.6K 0.45% 52
2025
Q4
$1.24M Buy
2,202
+25
+1% +$14.2K 0.52% 47
2025
Q3
$1.12M Sell
2,177
-10
-0.5% -$4.37K 0.48% 50
2025
Q2
$686K Sell
2,187
-493
-18% -$148K 0.3% 71
2025
Q1
$817K Buy
2,680
+50
+2% +$16.8K 0.36% 60
2024
Q4
$874K Buy
2,630
+30
+1% +$10.2K 0.32% 57
2024
Q3
$868K Buy
2,600
+270
+12% +$103K 0.36% 61
2024
Q2
$960K Buy
2,330
+4
+0.2% +$1.58K 0.43% 57
2024
Q1
$940K Buy
2,326
+76
+3% +$26.7K 0.41% 59
2023
Q4
$690K Hold
2,250
0.33% 65
2023
Q3
$545K Buy
2,250
+45
+2% +$11.5K 0.28% 71
2023
Q2
$530K Buy
2,205
+125
+6% +$26K 0.25% 75
2023
Q1
$391K Buy
2,080
+75
+4% +$15.5K 0.18% 82
2022
Q4
$426K Sell
2,005
-1,000
-33% -$200K 0.2% 78
2022
Q3
$472K Sell
3,005
-50
-2% -$7.98K 0.25% 71
2022
Q2
$457K Hold
3,055
0.21% 75
2022
Q1
$499K Buy
3,055
+260
+9% +$42.9K 0.21% 75
2021
Q4
$608K Buy
2,795
+25
+0.9% +$5.24K 0.25% 67
2021
Q3
$524K Buy
2,770
+275
+11% +$50.2K 0.24% 71
2021
Q2
$440K Buy
2,495
+40
+2% +$6.9K 0.19% 75
2021
Q1
$402K Hold
2,455
0.18% 78
2020
Q4
$341K Hold
2,455
0.17% 82
2020
Q3
$274K Buy
2,455
+25
+1% +$2.89K 0.15% 84
2020
Q2
$226K Buy
+2,430
New +$207K 0.13% 92

Other funds holding MEDP

Schulhoff & Co's MEDP Position: Q2 2026 in Review

Schulhoff & Co increased its Medpace (MEDP) stake by 0.17% in Q2 2026, buying an estimated $1.85K and bringing the position to 2,299 shares worth $1.22M. The position accounts for 0.49% of the portfolio, ranked #48.

Schulhoff & Co first reported a position in MEDP in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.24M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Schulhoff & Co held 2,299 shares of Medpace worth $1.22M as of Q2 2026.
  • Schulhoff & Co bought 4 Medpace shares in Q2 2026, an estimated $1.85K.
  • Medpace made up 0.49% of Schulhoff & Co's portfolio in Q2 2026, its #48 holding.
  • Schulhoff & Co first reported a position in Medpace in Q2 2020 and has held it in 25 quarters since.
  • Schulhoff & Co's Medpace position peaked at $1.24M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Schulhoff & Co's 13F filing for Q2 2026, filed 13 Aug 2026.